Cite
MLA Citation
P. Neven et al.. “1850 Safety of everolimus plus exemestane in elderly patients with Hormone-Receptor-Positive (HR+), HER2- locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors (NSAIs): BALLET (CRAD001YIC04).” European journal of cancer, vol. 51, n.d., pp. S282–. http://access.bl.uk/ark:/81055/vdc_100030628126.0x00003b